UK MHRA: ‘At Least Half’ Of Novel Drug Filings To Take National Assessment Route

 
• By Ian Schofield
  
Innovation light bulb
The MHRA is expecting a rise in filings for innovative drugs (Shutterstock)

More from Agency Leadership

More from Pathways & Standards